COX inhibitor Fenbufen, Purity ≥98%

Synonym: Fenbufen; 36330-85-5; Lederfen; Cinopal; Bufemid; Napanol; 4-(4-Biphenylyl)-4-oxobutyric acid; COX inhibitor

MDL: MFCD00056701
CAS Number: 36330-85-5
Compound CID: 3335

Product Size

100 mg; 250 mg; 500 mg; 1000 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Fenbufen, soluble in DMSO and ethanol and insoluble in water, blocks the COX enzymes from converting arachidonic acid to prostaglandins, thereby reducing inflammatory reactions. It targets cyclooxygenase and ATP systhesis.

Molecular Weight

254.28

Molecular Formula

C₁₆H₁₄O₃

Targets

cyclooxygenase; ATP systhesis: 0.88 μM (Ki)

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 45 mg/mL (176.97 mM); Water: Insoluble; Ethanol: 45 mg/mL (176.97 mM)

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

Fenbufen is used in studies focusing on its anti-inflammatory and pain relief properties, often in the context of arthritis and other inflammatory conditions.

Storage

Store at -20ºC.